A 60-unit housing complex which accepts referrals from the Coordinated Entry list and applications to property management. Tellurian provides clinical case management and supportive services on site to individuals. Targeted case management and CCS service facilitation services provide crisis stabilization, symptom management, service coordination, and housing support to those living at Enso.
Opioid dependence is a challenging and complicated condition, but it can be successfully treated; Suboxone® is the first prescription medication approved for this under the Drug Addiction Treatment Act of 2000. Suboxone® was developed to decrease the pain and discomfort of withdrawal and to decrease opiate cravings, blocking the effects of drugs like heroin, morphine, Vicodin, Oxycodone, and Oxycontin.
Suboxone® is not a “miracle cure.” Treating opioid dependence takes hard work! Feeling sadness, anxiety, and loneliness along the way is normal, but our team does everything we can to make joy and laughter part of the journey too. The Tellurian Suboxone® Treatment Program follows three distinct phases:
A staff physician and therapist review medical records and psychosocial history during a medical exam and intake process to see if Suboxone® is right for a patient. If the drug is prescribed, dosages are regularly adjusted and intensive group and individual therapy starts.
This phase focuses on continued weekly group and individual counseling. Medication checks occur monthly, and random drug screens will happen.
Monthly individual counseling and group therapy sessions continue as patients learn to rebuild their lives free from addiction.